The buzz: This Tewksbury, MA, company is developing a minimally invasive transcatheter heart implant, the first technology of its kind to treat diastolic heart failure without relying on invasive surgery. Surgeons insert the device into the atrial septum in order to reduce pressure, and investors are paying attention.
Milestone: DC Devices nailed down $10.7 million in new funding just this March ($23 million to date), drawing participation from Lumira Capital, Third Rock Ventures and General Catalyst. Plans call for using the money to fund a European pilot trial for the company's InterAtrial Shunt device.
DC Devices hauls in another $10.7 million